Action on IV pantoprazole shortage

July 9, 2024

In this collaborative reference document, CSHP and the Canadian Association of Gastroenterology make specific recommendations on how to handle the current shortage of IV pantoprazole. This shortage, affecting the Canadian market due to backorders from the primary suppliers, is expected to persist until October 2024. In the interim, healthcare facilities are encouraged to implement conservation strategies, such as transitioning from IV to oral pantoprazole, restricting IV pantoprazole use, and considering intermittent dosing to manage the shortage effectively. This letter underscores the importance of these measures to ensure the prolonged availability of this essential medication.

CSHP has requested that Health Canada consider other IV options for approval, including making another IV alternative available in the Canadian landscape.

Read the joint letter

Read the recommendations

To catch up on other CSHP advocacy news, click here.

Have a question about CSHP's advocacy and consultation work?
Reach out to our professional practice team!